Presentación nº 22

ALSUntangled No. 22: Propofol.

ISSN 2167-8421 print/ISSN 2167-9223 online © 2013 Informa Healthcare DOI: 10.3109/21678421.2013.826469 neuroinfl ammation (18,19) occur in ALS, although attempts to manipulate these events have not yet shown clear benefi ts in human ALS trials. Propofol has a short half-life; once infusion is stopped, its clinical effects last only minutes (3). For this reason, it is diffi cult to understand ho...

Presentación CITA 2009

This editorial is an introduction of the special issue composed with the best papers in e-learning of CITA2009 (Congreso Iberoamericano de Telemática). This congress was organized in Gijón/Xixón, Asturies, España, in May of 2009. The two selected papers are related with different matters of elearning, such as learning objects and system architecture. In this editorial we introduce CITA 2009 and...

Presentación De La Asignatura

Correction: Vol. 22, No. 8

Author affiliations: University of Helsinki, Helsinki, Finland (M. Meriluoto, L. Hedman, M. Knip, K. Hedman, M. Söderlund-Venermo); Helsinki University Central Hospital, Helsinki (L. Hedman, M. Knip, K. Hedman); University of Turku, Turku, Finland (L. Tanner, V. Simell, M. Mäkinen, S. Simell, J. Mykkänen, J. Korpelainen, O. Ruuskanen, J. Ilonen, O. Simell); University of Eastern Finland, Kuopio...

Correction: Vol. 22, No. 1